Pharmacokinetics and molecular-level insights into 5-Methyl-3-(trifluoromethyl)-1H-pyrazole for anticancer action: Spectroscopic profiling, solvent interactions, topological analysis and ADME–QSAR predictions
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · 2026
DOI: 10.1016/j.saa.2025.126940 ↗Kurz gefasst
Fachartikel in der Zeitschrift Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2026. Verfasst von M Thirunavukkarasu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology, Avadi, Chennai 600062, India. Electronic address: …. Hauptthemen laut MEDLINE: Pyrazoles, Antineoplastic Agents, Solvents, Quantitative Structure-Activity Relationship. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Rob Dollar Foundation, Deanship of Scientific Research, King Khalid University, King Khalid University.
Abstract (Originalsprache)
This study investigated the structural and spectroscopic characteristics of 5-methyl-3-(trifluoromethyl)-1H-pyrazole through PXRD/Rietveld refinement and DFT methods. A PES scan revealed two conformers, with Conformer I exhibiting the lowest energy at -602.619 Hartree (a.u.). Structural and topological analyses, including AIM, LOL, ELF, and RDG, were conducted, extended to dimeric and trimeric forms to elucidate intermolecular interactions. Vibrational analysis (FT-IR and FT-Raman) was performed to identify functional groups and bonding features, while 1H/13C NMR studies were conducted to analyse chemical shift variations associated with the dimeric and trimeric forms. Solvent effect on reactivity was assessed using FMO analysis. Intermolecular hydrogen bonding and crystal structure were characterized using Hirshfeld-surface analysis. Experimental and theoretical UV-Vis absorption spectra across various solvents have pinpointed regions of electronic transitions. Solute-solvent interaction parameters (π∗,α and β) with a correlation (R2 = 0.93789) revealed a strong influence of solvent polarity and hydrogen-bonding properties on the absorption maxima (λmax) of the compound. ADMET predictions indicate strong drug-development potential with high blood-brain barrier (BBB) penetration, low metabolic liability, and good oral bioavailability, but minimal hERG inhibition. The compound showed binding energies of -8.47 and - 8.01 kcal mol-1 against MAP3K14 (NIK) target proteins, suggesting potential anticancer activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physics, Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology, Avadi, Chennai 600062, India. Electronic address: thirusharwin@gmail.com.
- Department of Physics, Vel Tech Rangarajan Dr. Sagunthala R&D Institute of Science and Technology, Avadi, Chennai 600062, India.
- Department of Chemistry, Faculty of Science, King Khalid University, Abha 61413, Saudi Arabia; Research Centre for Advanced Materials Science (RCAMS), King Khalid University, AlQura'a, Abha, P.O. Box 960, Saudi Arabia.
- Department of Physics, Loyola College, Chennai 600 034, Tamil Nadu, India.
- Department of Physics, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Thandalam, Chennai 602105, Tamil Nadu, India.
- Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, 603203, Chengalpattu, Tamil Nadu, India.
Förderung
- Rob Dollar Foundation
- Deanship of Scientific Research, King Khalid University
- King Khalid University
- King Khalid University Research Center for Advanced Material Science
Zitieren
APA
Thirunavukkarasu, M., Monika, R., Nithya, S., Selvaraj, M., Assiri, M. A., Prabakaran, P., Selvaraj, S., & Thirumurugan, D. (2026). Pharmacokinetics and molecular-level insights into 5-Methyl-3-(trifluoromethyl)-1H-pyrazole for anticancer action: Spectroscopic profiling, solvent interactions, topological analysis and ADME–QSAR predictions. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. https://doi.org/10.1016/j.saa.2025.126940
Vancouver
Thirunavukkarasu M, Monika R, Nithya S, Selvaraj M, Assiri MA, Prabakaran P, et al. Pharmacokinetics and molecular-level insights into 5-Methyl-3-(trifluoromethyl)-1H-pyrazole for anticancer action: Spectroscopic profiling, solvent interactions, topological analysis and ADME–QSAR predictions. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2026. doi:10.1016/j.saa.2025.126940
BibTeX
@article{Thirunavukkarasu2026,
author = {Thirunavukkarasu, M and Monika, R and Nithya, S and Selvaraj, Manickam and Assiri, Mohammed A and Prabakaran, P and Selvaraj, S and Thirumurugan, D},
title = {Pharmacokinetics and molecular-level insights into 5-Methyl-3-(trifluoromethyl)-1H-pyrazole for anticancer action: Spectroscopic profiling, solvent interactions, topological analysis and ADME–QSAR predictions},
journal = {Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy},
year = {2026},
doi = {10.1016/j.saa.2025.126940}
}
EUVIMED